In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis

W M Obermann, H Sondermann, A A Russo, N P Pavletich, F U Hartl, W M Obermann, H Sondermann, A A Russo, N P Pavletich, F U Hartl

Abstract

Heat shock protein 90 (Hsp90), an abundant molecular chaperone in the eukaryotic cytosol, is involved in the folding of a set of cell regulatory proteins and in the re-folding of stress-denatured polypeptides. The basic mechanism of action of Hsp90 is not yet understood. In particular, it has been debated whether Hsp90 function is ATP dependent. A recent crystal structure of the NH2-terminal domain of yeast Hsp90 established the presence of a conserved nucleotide binding site that is identical with the binding site of geldanamycin, a specific inhibitor of Hsp90. The functional significance of nucleotide binding by Hsp90 has remained unclear. Here we present evidence for a slow but clearly detectable ATPase activity in purified Hsp90. Based on a new crystal structure of the NH2-terminal domain of human Hsp90 with bound ADP-Mg and on the structural homology of this domain with the ATPase domain of Escherichia coli DNA gyrase, the residues of Hsp90 critical in ATP binding (D93) and ATP hydrolysis (E47) were identified. The corresponding mutations were made in the yeast Hsp90 homologue, Hsp82, and tested for their ability to functionally replace wild-type Hsp82. Our results show that both ATP binding and hydrolysis are required for Hsp82 function in vivo. The mutant Hsp90 proteins tested are defective in the binding and ATP hydrolysis-dependent cycling of the co-chaperone p23, which is thought to regulate the binding and release of substrate polypeptide from Hsp90. Remarkably, the complete Hsp90 protein is required for ATPase activity and for the interaction with p23, suggesting an intricate allosteric communication between the domains of the Hsp90 dimer. Our results establish Hsp90 as an ATP-dependent chaperone.

Figures

Figure 1
Figure 1
Structure of the NH2-terminal domain of Hsp90 with bound ADP-Mg. View into the nucleotide-binding pocket. The residues D93 and E47, critical for nucleotide binding and hydrolysis, respectively, are colored in yellow. Image was prepared with the programs MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merrit and Murphy, 1994).
Figure 2
Figure 2
Mutations in the nucleotide-binding site of Hsp90 abolish the function of Hsp90 in vivo. (A) Yeast strain ΔPCLDa/α that expresses wild-type Hsc82 from the plasmid pKAT6 (containing the URA3-marker) was cotransformed with wild-type HSP82 (lane 1), HSP82His6EEF (lane 2), HSP82(E33A)His6EEF (lane 3), HSP82(E33D)His6EEF (lane 4) and HSP82(D79N) His6EEF (lane 5). After growth to mid-log phase in liquid SD/ −Trp/−Ura, cell lysates were prepared, adjusted to equal protein concentrations and His6EEF tagged proteins quantitatively absorbed with Ni-NTA beads followed by SDS-PAGE and Coomassie staining (lanes 1–5). Lanes 6–10 correspond to lanes 1–5 and show an immunoblot with the EEF-specific antibody. Note that only the band at ∼90 kD (and two degradation products at ∼60 and ∼50 kD, generated during isolation) are specifically recognized. (B) The cotransformants described in A were restreaked on 5-FOA plates at 25°C to select for cells that had lost the original wild-type plasmid and were rescued from lethality by a functional hsp82 protein. Only wild-type Hsp82, Hsp82His6EEF, and the E33D mutant were able to support growth.
Figure 3
Figure 3
Mutations in the nucleotide binding site of Hsp90 affect ATP binding and hydrolysis differentially. (A) Binding of ATP to the NH2-domains of wild-type and mutant Hsp82 in the presence and absence of GA (see Materials and Methods). Averages of three independent experiments are shown with error bars. (B) A typical plot of ATP hydrolysis versus time at a concentration of 0.05 mM ATP and 10 μM Hsp82. ATPase activity was measured with [α32P]ATP at 30°C as described in Materials and Methods. The ATPase activity of Hsp82 (closed circles) and the E33D mutant (closed triangles) is specifically inhibited by GA (open circles and open triangles, respectively). In contrast, the E33A (closed squares) and D79N mutants (open squares) are devoid of GA-inhibitable ATPase activity. (C) Double reciprocal plot of the rate of ATP hydrolysis versus ATP concentration. Km values for wild-type Hsp82 (closed circles) and for the E33D mutant (closed triangles) were determined as 172 μM and 520 μM, respectively.
Figure 4
Figure 4
The complete Hsp90 protein is required for ATPase activity. ATP hydrolysis versus time at 0.10 mM ATP and 10 μM Hsp82 proteins at 30°C is shown for full-length Hsp82 (FL82, closed circles), the NH2 domain of Hsp82 (N82, closed triangles) and for ΔC82, lacking the COOH-terminal residues 600–709 (closed squares).
Figure 5
Figure 5
Requirement of full-length Hsp90 with an intact ATP-binding site for the interaction with p23 in vivo. (A) Schematic representation of the domain structure of human Hsp90 established by limited proteolysis (Stebbins et al., 1997) and of the fragments used in the two-hybrid assay. (B) Different fragments of Hsp90 in the pAS2-1 bait vector were cotransformed in S. cerevisiae (strain Y190) with the cDNA encoding human p23 in the pACT2 target vector (see Materials and Methods). To monitor protein–protein interactions, cotransformants were restreaked on SD/−Trp/−Leu/−His plates containing 25 mM 3-AT and incubated for 5 d at 30°C. Cell growth was only observed with full-length Hsp90 protein but not for any of its subfragments or for the vector control without insert. (C) Full-length wild-type Hsp90 and the mutants E47A, E47D, and D93N were analyzed for their ability to interact with p23 by two-hybrid assay as above. Cell growth was observed for wild-type Hsp90, the E47A and E47D mutants, but not for the D93N mutant.
Figure 5
Figure 5
Requirement of full-length Hsp90 with an intact ATP-binding site for the interaction with p23 in vivo. (A) Schematic representation of the domain structure of human Hsp90 established by limited proteolysis (Stebbins et al., 1997) and of the fragments used in the two-hybrid assay. (B) Different fragments of Hsp90 in the pAS2-1 bait vector were cotransformed in S. cerevisiae (strain Y190) with the cDNA encoding human p23 in the pACT2 target vector (see Materials and Methods). To monitor protein–protein interactions, cotransformants were restreaked on SD/−Trp/−Leu/−His plates containing 25 mM 3-AT and incubated for 5 d at 30°C. Cell growth was only observed with full-length Hsp90 protein but not for any of its subfragments or for the vector control without insert. (C) Full-length wild-type Hsp90 and the mutants E47A, E47D, and D93N were analyzed for their ability to interact with p23 by two-hybrid assay as above. Cell growth was observed for wild-type Hsp90, the E47A and E47D mutants, but not for the D93N mutant.
Figure 6
Figure 6
p23 binds the ATP-bound state of purified Hsp90 in vitro, not the ADP-bound and nucleotide-free forms. Wild-type and mutant Hsp82 proteins (200 μg each) were bound to Ni-NTA agarose via their His6 tags and incubated for 45 min at 30°C with yeast p23 (100 μg) and different combinations of nucleotides and GA as indicated (lanes 2–22). In lane 1 (control) Ni-NTA beads without bound Hsp82 were used. Protein was eluted from the beads with imidazole and analyzed by 15% SDS-PAGE and immunoblotting for the T7 immunotag of p23 (see Materials and Methods).

References

    1. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1987. Current Protocols in Molecular Biology. Wiley and Sons, Inc., New York. 8.5.1–8.5.9.
    1. Aligue R, Akhavan-Niak H, Russel P. A role for Hsp90 in cell cycle control: Wee 1 tyrosine kinase activity requires interaction with Hsp90. EMBO (Eur Mol Biol Organ) J. 1994;13:6099–6106.
    1. Bartel, P.L., C.-T. Chien, R. Sternglanz, and S. Fields. 1993. Using the two-hybrid system to detect protein–protein interactions. In Cellular Interactions in Development: A Practical Approach. D.A. Hartley, editor. Oxford University Press, Oxford. 153–179.
    1. Bohen SP. Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins. Mol Cell Biol. 1998;18:3330–3339.
    1. Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S. Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol. 1989;9:3919–3930.
    1. Bose S, Weikl T, Bugl H, Buchner J. Chaperone function of Hsp90-associated proteins. Science. 1996;274:1715–1717.
    1. Buchner J. Supervising the fold: functional principles of molecular chaperones. FASEB (Fed Am Soc Exp Biol) J. 1996;10:10–19.
    1. Chen SY, Prapapanich V, Rimerman RA, Honore B, Smith DF. Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins Hsp90 and Hsp70. Mol Endocrinol. 1996;10:682–693.
    1. Craig EA. Chaperones: helpers along the pathways to protein folding. Science. 1993;260:1902–1903.
    1. Csermely P, Kahn CR. The 90 kD heat-shock protein (Hsp-90) possesses an ATP binding site and autophosphorylation activity. J Biol Chem. 1991;266:4943–4950.
    1. Csermely P, Kajtar J, Hollosi M, Jalsovszky G, Holly S, Kahn CR, Gergely PJ, Soti C, Mihaly K, Somogyi J. ATP induces a conformational change of the 90-kD heat shock protein (hsp90) J Biol Chem. 1993;268:1901–1907.
    1. Dittmar KD, Pratt WB. Folding of the glucocorticoid receptor by the reconstituted hsp90-based chaperone machinery. J Biol Chem. 1997;272:13047–13054.
    1. Dittmar KD, Hutchison KA, Owens-Grillo JK, Pratt WB. Reconstitution of the steroid receptor-center-dot-hsp90 heterocomplex assembly system of rabbit reticulocyte lysate. J Biol Chem. 1996;271:12833–12839.
    1. Fang YF, Fliss AE, Rao J, Caplan AJ. Sba1 encodes a yeast Hsp90 cochaperone that is homologous to vertebrate p23 proteins. Mol Cell Biol. 1998;18:3727–3734.
    1. Freeman BC, Morimoto RI. The human cytosolic molecular chaperones Hsp90, Hsp70 (Hsc70) and Hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO (Eur Mol Biol Organ) J. 1996;15:2969–2979.
    1. Frydman J, Höhfeld J. Chaperones get in touch: the Hip-Hop connection. Trends Biochem Sci. 1997;22:87–92.
    1. Gething M-J, Sambrook J. Protein folding in the cell. Nature. 1992;355:33–45.
    1. Grenert JP, Sullivan WP, Fadden P, Haystead TA, Clark J, Mimnaugh E, Krutzsch H, Ochel H-J, Schulte TW, Sausville E, et al. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem. 1997;272:23843–23850.
    1. Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996;381:571–580.
    1. Höhfeld J. Regulation of the heat shock cognate hsc70 in the mammalian cell: the characterization of the anti-apoptotic protein BAG-1 provides novel insights. Biol Chem. 1998;379:269–274.
    1. Jackson AP, Maxwell A. Identifying the catalytic residue of the ATPase reaction of DNA gyrase. Proc Natl Acad Sci USA. 1993;90:11232–11236.
    1. Jakob U, Lilie H, Meyer I, Buchner J. Transient interaction of Hsp90 with early unfolding intermediates of citrate synthase—Implications for heat shock in vivo. J Biol Chem. 1995;270:7288–7294.
    1. Jakob U, Scheibel T, Bose S, Reinstein J, Buchner J. Assessment of the ATP binding properties of Hsp90. J Biol Chem. 1996;271:10035–10041.
    1. Johnson BD, Schumacher RJ, Ross ED, Toft DO. Hop modulates hsp70/hsp90 interactions in protein folding. J Biol Chem. 1998;273:3679–3686.
    1. Johnson JL, Craig EA. Protein folding in vivo: unraveling complex pathways. Cell. 1997;90:201–204.
    1. Johnson JL, Toft DO. A novel chaperone complex for steroid receptors involving heat shock proteins, immunophilins, and p23. J Biol Chem. 1994;269:24989–24993.
    1. Johnson JL, Toft DO. Binding of p23 and Hsp90 during assembly with progesterone-receptor. Mol Endocrinol. 1995;9:670–678.
    1. Johnson JL, Beito TG, Krco CJ, Toft DO. Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes. Mol Cell Biol. 1994;14:1956–1963.
    1. Kraulis PJ. Molscript: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr. 1991;24:946–950.
    1. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature. 1970;227:680–685.
    1. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet. 1988;22:631–677.
    1. Merrit EA, Murphy ME. Raster3D Version 2.0: a program for photorealistic molecular graphics. Acta Crystallogr Sect D Biol Crystallogr. 1994;50:946–950.
    1. Nair SC, Toran EJ, Rimerman RA, Hjermstad S, Smithgall TE, Smith DF. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress Chaperones. 1996;1:237–250.
    1. Nathan DF, Lindquist S. Mutational analysis of hsp90 function: interactions with a steroid receptor and a protein kinase. Mol Cell Biol. 1995;15:3917–3925.
    1. Nathan DF, Vos MH, Lindquist S. In vivo functions of the Saccharomyces cerevisiaeHsp90 chaperone. Proc Natl Acad Sci USA. 1997;94:12949–12956.
    1. Nemoto T, Oharanemoto Y, Ota M, Takagi T, Yokoyama K. Mechanism of dimer formation of the 90-kD heat-shock protein. Eur J Biochem. 1995;233:1–8.
    1. O'Brien MC, McKay DB. Threonine 204 of the chaperone protein Hsc70 influences the structure of the active site, but is not essential for ATP hydrolysis. J Biol Chem. 1993;268:24323–24329.
    1. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 1997;18:306–360.
    1. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell. 1997a;90:65–75.
    1. Prodromou C, Roe SM, Piper PW, Pearl LH. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat Struct Biol. 1997b;4:477–482.
    1. Scheibel T, Neuhofen S, Weikl T, Mayr C, Reinstein J, Vogel PD, Buchner J. ATP-binding properties of human Hsp90. J Biol Chem. 1997;272:18608–18613.
    1. Scheibel T, Weikl T, Buchner J. Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc Natl Acad Sci USA. 1998;95:1495–1499.
    1. Schneider C, Sepp-Lorenzino L, Nimmesgern E, Ouerfelli O, Danishefsky S, Rosen N, Hartl FU. Pharmacological shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc Natl Acad Sci USA. 1996;93:14536–14541.
    1. Schumacher RJ, Hansen WJ, Freeman BC, Alnemri E, Litwack G, Toft DO. Cooperative action of hsp70, hsp90, and DnaJ proteins in protein renaturation. Biochemistry. 1996;35:14889–14898.
    1. Sikorski R, Boeke JD. In vitro mutagenesis and plasmid shuffling: from cloned gene to mutant yeast. Methods Enzymol. 1991;194:302–318.
    1. Smith DF. Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol Endocrinol. 1993;7:1418–1429.
    1. Smith DF. Sequence motifs shared between chaperone components participating in the assembly of progesterone receptor complexes. Biol Chem. 1998;379:283–288.
    1. Smith DF, Whitesell L, Nair SC, Chen SY, Prapapanich V, Rimerman RA. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol. 1995;15:6804–6812.
    1. Stancato LF, Silverstein AM, Owens-Grillo JK, Chow YH, Jove R, Pratt WB. The hsp90 binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J Biol Chem. 1997;272:4013–4020.
    1. Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 1997;89:239–250.
    1. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89.
    1. Sullivan W, Stensgard B, Caucutt G, Bartha B, McMahon N, Alnemri ES, Litwack G, Toft D. Nucleotides and two functional states of hsp90. J Biol Chem. 1997;272:8007–8012.
    1. Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350–4354.
    1. Wearsch PA, Nicchitta CV. Endoplasmic reticulum chaperone GRP94 subunit assembly is regulated through a defined oligomerization domain. Biochemistry. 1996;35:16760–16769.
    1. Wehland J, Schröder HC, Weber K. Amino sequence requirements in the epitope recognized by the α-tubulin-specific ray monoclonal antibody YL 1/2. EMBO (Eur Mol Biol Organ) J. 1984;3:1295–1300.
    1. Wei J, Hendershot LM. Characterization of the nucleotide binding properties and ATPase activity of recombinant hamster Bip purified from bacteria. J Biol Chem. 1995;270:26670–26676.
    1. Whitesell L, Cook P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol. 1996;10:705–712.
    1. Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA. 1994;91:8324–8328.
    1. Wiech H, Buchner J, Zimmermann R, Jacob U. Hsp90 chaperones protein folding in vitro. Nature. 1992;358:169–170.
    1. Wigley DB, Davies GJ, Dodson EJ, Maxwell A, Dodson G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature. 1991;351:624–629.
    1. Young JC, Schneider C, Hartl FU. In vitro evidence that hsp90 contains two independent chaperone sites. FEBS (Fed Eur Biochem Soc) Lett. 1997;418:139–143.
    1. Young JC, Obermann WMJ, Hartl FU. Specific binding of tetratricopeptide-repeat proteins to the C-terminal 12 kD domain of Hsp90. J Biol Chem. 1998;273:18007–18010.

Source: PubMed

3
Suscribir